IBRX ImmunityBio
- 5.040
- -0.060-1.18%
- 5.020
- -0.020-0.40%
ImmunityBio News
ImmunityBio | 8-K: Current report
ImmunityBio | 8-K: ImmunityBio Reports Third-Quarter 2024 Financial Results
ImmunityBio | 10-Q: Q3 2024 Earnings Report
ImmunityBio | 10-Q: Q2 2024 Earnings Report
ImmunityBio | 8-K: Current report
ImmunityBio | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
ImmunityBio | 4: Statement of changes in beneficial ownership of securities-Director Brennan John Owen
ImmunityBio | 4: Statement of changes in beneficial ownership of securities-Director Clark Wesley
ImmunityBio | 4: Statement of changes in beneficial ownership of securities-Director Cohen Cheryl
ImmunityBio | 4: Statement of changes in beneficial ownership of securities-Director Selecky Christobel
ImmunityBio | 4: Statement of changes in beneficial ownership of securities-Director BLASZYK MICHAEL D
ImmunityBio | 4: Statement of changes in beneficial ownership of securities-Director MAXWELL LINDA
ImmunityBio | 8-K: Current report
ImmunityBio | 10-Q: Q1 2024 Earnings Report
ImmunityBio | EFFECT: Others
ImmunityBio | CORRESP: CORRESP
ImmunityBio | DEFA14A: Others
ImmunityBio | DEF 14A: Definitive information statements
ImmunityBio | ARS: Annual Report to Security Holders
ImmunityBio | 8-K: Current report
Analysis
Price Target
No Data
No Data